Excellence in Pharmaceutical Research & Innovation
We, among Indian pharmaceutical companies, see tremendous value in investing in Research and Development (R&D). Our core strength lies in our ability to excel in developing generics and technologically complex products through focused teams in formulations, process chemistry, and analytical development. We have the capability to deliver quality products within established timelines, at low costs, and without compromising on quality.
KEY FEATURES
Cutting-Edge R&D Facilities
We have many research scientists working in multiple R&D centers equipped with cutting-edge enabling technologies for research. Our scientists have expertise in developing generics, difficult-to-make technology-intensive products, Active Pharmaceutical Ingredients (APIs), Novel Drug Delivery Systems (NDDS), and New Chemical Entities (NCEs).
Expertise in Differentiated Products
Our capabilities span the development of differentiated products such as liposomal products, inhalers, lyophilized injections, nasal sprays, and controlled-release dosage forms. We leverage advanced pharmaceutical technologies to ensure product innovation and efficiency.
Advanced Formulation Development
Our expertise in pharmaceutical research allows us to rapidly develop a diverse range of immediate and novel delivery systems across Oral, Parenteral, Topical, and Inhalation Dosage Forms. We specialize in formulation techniques such as taste masking, spray-drying, drug-layering, nano-milling, lyophilization, and other pharmaceutical unit operations, enabling us to cater to various formulation design needs.
Complex API Development
The ability to develop difficult-to-make, complex APIs using the latest technologies is a key differentiating factor in our research. Our advanced methodologies ensure high-quality and cost-effective production of pharmaceutical ingredients.
Innovative Market-Driven Research
Our scientists collaborate closely with our business development team to generate innovative concepts and ideas by identifying market needs and synergies across therapeutic areas. We invest 7-8% of our revenues annually in research, continuously monitoring research efficiency to maintain high R&D productivity, ranking among the highest for Indian generic companies.
Clinical Studies & Bioequivalence Research
Over the years, we have developed expertise in performing pharmacokinetic and bioequivalence studies to facilitate the introduction of generic or branded generic drugs into the international market. Our facilities include a full-fledged site for Phase I clinical studies, ensuring regulatory compliance and product effectiveness.
Strong Intellectual Property Strategy
Our research strategy is backed by a strong intellectual property team with expertise in chemistry, analytical techniques, dosage forms, and global patent law. Our research capabilities have not only contributed to our business success but have also earned us an enviable reputation for quality and innovation in the pharmaceutical industry.
